Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GILD
GILD logo

GILD News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GILD News

WHO Launches Clinical Trial for Ebola Treatments

2d agoseekingalpha

Major US Biopharmaceutical Companies Expected to Underperform in H2

14h agoYahoo Finance

Key Wall Street Rating Updates on Monday

2d agoCNBC

Gilead's Trodelvy Receives FDA Approval for Expanded Use

Jun 27 2026Yahoo Finance

Biotech Sector Update: FDA and EU Approvals

Jun 26 2026NASDAQ.COM

FDA Approves Trodelvy for First-Line Treatment of Metastatic TNBC

Jun 25 2026NASDAQ.COM

QQQ ETF Outperforms S&P 500 Over Last Decade

Jun 25 2026Fool

FDA Approves Trodelvy for First-Line Treatment of Triple-Negative Breast Cancer

Jun 25 2026NASDAQ.COM

GILD Events

07/07 10:00
DoorDash Gains 10.06% to $198.52
Notable gainers among liquid option names this morning include DoorDash (DASH) $198.52 +10.06, Fiserv Inc (FISV) $54.25 +2.47, GoDaddy (GDDY) $89.52 +3.91, Charter (CHTR) $141.57 +6.13, and Gilead (GILD) $134.94 +5.33.

GILD Monitor News

WHO Launches Clinical Trial for Ebola Treatments Involving Gilead's Remdesivir

Jul 07 2026

Gilead and Merck's HIV Treatment Trials Show Promise Amid Market Decline

Jun 10 2026

Gilead and Merck's HIV Treatment Trials Show Promise Amid Market Challenges

Jun 09 2026

Gilead Sciences Faces Pressure Amid Market Decline

Mar 20 2026

Gilead's Yescarta Label Update Approved by FDA

Feb 11 2026

Gilead's Trodelvy and Keytruda Combo Shows 35% Death Risk Reduction

Jan 23 2026

Gilead Sciences reaches 20-day high amid market gains

Jan 21 2026

Gilead Sciences hits 20-day low amid market strength

Jan 05 2026

GILD Earnings Analysis

Gilead Sciences Q1 2025 Earnings: Growth Amid Challenges- Intellectia AI™
1 years ago
Gilead Sciences Q4 2024 Financial Performance Review - Intellectia AI™
1 years ago

People Also Watch